Disclosures

Branmoor is an independent intelligence infrastructure company. Public pages are previews; complete products, exports, APIs, feeds, and diligence work are licensed.

Effective: 2026-05-12 · Last updated: 2026-05-12

Commercial relationships

Branmoor's commercial model is licensed access: diligence sheets, watchlists, APIs, data feeds, bulk exports, and buyer-specific analysis. Preview pages do not grant redistribution, scraping, API, or automated data-feed rights.

What we do not do

• We do not accept payment for editorial coverage or product placement.
• We do not allow drug manufacturers, pharmacies, payers, or other commercial entities to influence which drugs, shortages, recalls, or other data we cover, or how we cover them.
• We do not run third-party behavioral advertising. We do not allow third parties to track Branmoor visitors for advertising purposes.

Editorial independence

Coverage on Branmoor is determined by the underlying primary-source data feeds (chiefly the U.S. Food and Drug Administration), the editorial judgment of Branmoor, and the methodology disclosed on the Methodology page for each product. Commercial relationships do not affect what we cover, how we cover it, or where products appear in any register or listing.

Paid Branmoor products

Branmoor sells institutional products under separate written agreements (such as ClearRate, listed on the Products page). These are direct sales to identified institutional customers, not affiliate or advertising relationships, and are governed by their own master services agreements, statements of work, data licenses, or API terms.

FTC compliance

This page is published in accordance with the U.S. Federal Trade Commission's Guides Concerning the Use of Endorsements and Testimonials in Advertising (16 CFR Part 255) and analogous state rules.

Contact

For questions about Branmoor's commercial relationships or licensing, email disclosures@branmoor.com.